1. Home
  2. RRR vs STVN Comparison

RRR vs STVN Comparison

Compare RRR & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Rock Resorts Inc.

RRR

Red Rock Resorts Inc.

HOLD

Current Price

$52.95

Market Cap

3.4B

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$17.56

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RRR
STVN
Founded
1976
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Hotels/Resorts
Containers/Packaging
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
RRR
STVN
Price
$52.95
$17.56
Analyst Decision
Strong Buy
Buy
Analyst Count
13
3
Target Price
$69.69
$25.67
AVG Volume (30 Days)
875.1K
563.4K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.64%
0.39%
EPS Growth
23.32
N/A
EPS
3.12
N/A
Revenue
$2,011,483,000.00
N/A
Revenue This Year
$3.41
$9.67
Revenue Next Year
$4.62
$9.99
P/E Ratio
$17.47
$27.15
Revenue Growth
3.74
N/A
52 Week Low
$43.16
$12.89
52 Week High
$68.99
$28.00

Technical Indicators

Market Signals
Indicator
RRR
STVN
Relative Strength Index (RSI) 36.33 74.51
Support Level $52.41 $13.58
Resistance Level $59.48 $26.94
Average True Range (ATR) 1.71 0.78
MACD -0.12 0.27
Stochastic Oscillator 22.01 91.61

Price Performance

Historical Comparison
RRR
STVN

About RRR Red Rock Resorts Inc.

Red Rock Resorts Inc along with its subsidiary is a gaming, development and management company that develops and operates strategically-located casino and entertainment properties. Its casino properties are conveniently located throughout the Las Vegas valley and provide its customers a wide variety of entertainment and dining options. The majority of revenue is derived from Casinos, followed by Food and Beverages, Rooms and others.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: